Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Milan - Delayed Quote EUR

ARTERRA BIOSCIENCE (ARBS.MI)

Compare
2.1400
0.0000
(0.00%)
At close: April 10 at 4:36:31 PM GMT+2
Loading Chart for ARBS.MI
  • Previous Close 2.1400
  • Open 2.1000
  • Bid 2.0800 x --
  • Ask 2.1600 x --
  • Day's Range 2.1000 - 2.1400
  • 52 Week Range 1.7800 - 2.4000
  • Volume 1,500
  • Avg. Volume 8,019
  • Market Cap (intraday) 13.939M
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) 10.19
  • EPS (TTM) 0.2100
  • Earnings Date --
  • Forward Dividend & Yield 0.13 (6.37%)
  • Ex-Dividend Date May 5, 2025
  • 1y Target Est --

Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Napoli, Italy.

www.arterrabio.it

34

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ARBS.MI

View More

Performance Overview: ARBS.MI

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is FTSE MIB Index (FTSEMIB.MI) .

YTD Return

ARBS.MI
9.18%
FTSE MIB Index (FTSEMIB.MI)
0.46%

1-Year Return

ARBS.MI
17.26%
FTSE MIB Index (FTSEMIB.MI)
0.93%

3-Year Return

ARBS.MI
17.49%
FTSE MIB Index (FTSEMIB.MI)
37.49%

5-Year Return

ARBS.MI
25.71%
FTSE MIB Index (FTSEMIB.MI)
93.10%

Compare To: ARBS.MI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ARBS.MI

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    13.94M

  • Enterprise Value

    10.85M

  • Trailing P/E

    10.32

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.50

  • Price/Book (mrq)

    1.31

  • Enterprise Value/Revenue

    2.72

  • Enterprise Value/EBITDA

    5.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    36.90%

  • Return on Assets (ttm)

    6.43%

  • Return on Equity (ttm)

    13.02%

  • Revenue (ttm)

    3.64M

  • Net Income Avi to Common (ttm)

    1.34M

  • Diluted EPS (ttm)

    0.2100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.43M

  • Total Debt/Equity (mrq)

    3.23%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ARBS.MI

View More

Company Insights: ARBS.MI

Research Reports: ARBS.MI

View More

People Also Watch